Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nimotuzumab with Chemoradiotherapy for Locally Advanced Cervical Cancer
NCT03469531Phase 2Unknown
- Sponsor
- Southern Medical University Zhujiang Hospital
- Start
- Mar 2018
- Primary completion
- Mar 2021
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of nimotuzumab in cervical squamous cell carcinoma (CSCC), sponsored by Southern Medical University Zhujiang Hospital. Status: unknown.
02
Drugs
nimotuzumab
03
Conditions
cervical squamous cell carcinoma (CSCC)
Beyond the preview
Go deeper on NCT03469531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03469531.